Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Daniel Adriano Silva Manzano
Introduction
Daniel Adriano Silva Manzano is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the design of interleukin mimetics. With a total of nine patents to his name, his work has the potential to impact therapeutic approaches in immunology.
Latest Patents
Manzano's latest patents include groundbreaking designs such as "De novo design of potent and selective interleukin mimetics." This patent discloses de novo designed polypeptides that bind to the IL-2 receptor β heterodimer, IL-4 receptor α heterodimer, or IL-13 receptor α subunit. Additionally, he has developed "Split interleukin mimetics and their use," which describes conditionally active receptor agonists that, when activated, bind to the same receptors, along with methods for their application.
Career Highlights
Throughout his career, Manzano has worked with esteemed institutions such as the University of Washington and Stanford University. His innovative research has positioned him as a key figure in the development of new therapeutic strategies targeting interleukin pathways.
Collaborations
Some of his notable collaborators include David Baker and Umut Ulge. Their combined expertise has contributed to the advancement of research in the field of immunology.
Conclusion
Daniel Adriano Silva Manzano's work exemplifies the spirit of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science through the design of novel therapeutic agents.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.